CervoMed
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $8 | $322 |
Gross Profit | 322 | |||
EBITDA | -6,571 | -7,964 | -8,087 | -7,726 |
EBIT | -7,726 | |||
Net Income | -6,571 | -7,964 | -8,087 | -7,726 |
Net Change In Cash | 0 | 0 | 8 | 322 |
Free Cash Flow | -6,918 | -8,018 | -6,575 | -6,465 |
Cash | 22,462 | 7,941 | 8,235 | 9,437 |
Basic Shares | 10,244 | 9,258 | 9,252 | 9,252 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,006 | $9,738 | $7,145 | $0 |
Gross Profit | -9,060 | -1,294 | -1,336 | |
EBITDA | -26,966 | -16,290 | -2,171 | -3,475 |
EBIT | -16,290 | -2,171 | -15,972 | |
Net Income | -26,966 | -16,290 | -2,171 | -15,591 |
Net Change In Cash | 4,006 | 9,738 | 7,145 | 0 |
Free Cash Flow | -23,449 | -16,530 | -7,449 | -2,572 |
Cash | 8,235 | 8,999 | 7,792 | 4,093 |
Basic Shares | 9,041 | 8,073 | 2,661 | 518 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.64 |
2026-03-31 | -$0.86 |
2025-12-31 | -$0.88 |
2025-09-30 | -$0.84 |